ArticleSaudi journal of biological sciences2020
Biogenic silver nanoparticle synthesis with cyanobacterium
Article in Saudi journal of biological sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 64 citations in OpenAlex.
- Article
- Antimicrobial and Cytotoxic Activities of Biogenic Nanoparticles Produced by Cyanobacteria.Chembiochem : a European journal of chemical biology · 2026Review
- Ligand-free palladium-catalyzed synthesis of 3-(2,2-dialkyl-2RSC advances · 2025Article
- Biosynthesis and characterisations of silver nanoparticles with filamentous cyanobacterium Lyngbya sp. with in vitro antibacterial properties against MDR pathogenic bacteria.Naunyn-Schmiedeberg's archives of pharmacology · 2024Article
- Antibacterial and cytotoxicity studies of pyrrolo-based organic scaffolds and their binding interaction with bovine serum albumin.Naunyn-Schmiedeberg's archives of pharmacology · 2024Article
- The effect of plasma activated water on antimicrobial activity of silver nanoparticles biosynthesized by cyanobacterium Alborzia kermanshahica.BMC biotechnology · 2024Article
- Unveiling the antibacterial and antifungal potential of biosynthesized silver nanoparticles from Chromolaena odorata leaves.Scientific reports · 2024Article
- Nanosynthesis, phycochemical constituents, and pharmacological properties of cyanobacterium Oscillatoria sp.Naunyn-Schmiedeberg's archives of pharmacology · 2024Review
- Prospective Phycocompounds for Developing Therapeutics for Urinary Tract Infection.Current microbiology · 2023Review
- Nanoparticles from Microalgae and Their Biomedical Applications.Marine drugs · 2023Review
- Biomedical Applications of Biosynthesized Gold Nanoparticles from Cyanobacteria: an Overview.Biological trace element research · 2022Review
- Marine-Bioinspired Nanoparticles as Potential Drugs for Multiple Biological Roles.Marine drugs · 2022Review
- Evaluation of silver nanoparticles in cosmeceutical and potential biosafety complications.Saudi journal of biological sciences · 2022Review
- Cyanobacteria as biochemical energy source for the synthesis of inorganic nanoparticles, mechanism and potential applications: a review.3 Biotech · 2021Review
- Silver Nanoparticles Biosynthesis, Characterization, Antimicrobial Activities, Applications, Cytotoxicity and Safety Issues: An Updated Review.Nanomaterials (Basel, Switzerland) · 2021Review
- Isolation, biosynthesis and antimicrobial activity of gold nanoparticles produced with extracts of Anabaena spiroides.Bioprocess and biosystems engineering · 2021Article
- Biosynthesized silver nanoparticles usingSaudi journal of biological sciences · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The burden from microbial diseases has to be addressed in an increasing pace due to multidrug resistance, causing clinical annoyance, globally. Indeed, employing eco-friendly approaches by green syntheses of nanoparticles with metals/metalloids as antibacterial compounds would be continual and cost-effective. Herein, the synthesis of silver nanoparticles (AgNPs) by aqueous extracts of the cyanobacterium
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.